DNTH

21.55

0.69% -0.15

Dopo l'orario di chiusura: 21.51 -0.04 -0.19%

Dianthus Therapeutics Inc (DNTH)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$21.70

Aprire:

$21.76

Volume 24 ore:

176.97K

Relative Volume:

0.55

Capitalizzazione di mercato:

$689.10M

Reddito:

$4.12M

Utile/perdita netta:

$-56.68M

Rapporto P/E:

-3.8879

EPS:

-5.5429

Flusso di cassa netto:

$-51.44M

1 W Prestazione:

+0.47%

1M Prestazione:

+33.68%

6M Prestazione:

-25.04%

1 anno Prestazione:

-16.47%

Intervallo 1D:

$20.11

$22.12

Intervallo di 1 settimana:

$20.11

$22.30

Portata 52W:

$13.37

$32.27

Dianthus Therapeutics Inc Stock (DNTH) Company Profile

Nome

Dianthus Therapeutics Inc

Settore

Healthcare (1150)

Industria

Biotechnology (676)

Telefono

929-999-4055

Indirizzo

7 TIMES SQUARE, NEW YORK

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

DNTH's Discussions on Twitter

Confronta DNTH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DNTH Dianthus Therapeutics Inc	21.55	689.10M	4.12M	-56.68M	-51.44M	-5.5429
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.58	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	254.16	26.92B	3.81B	-644.79M	-669.77M	-6.24

Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-20	Iniziato	TD Cowen	Buy
2024-10-03	Iniziato	Oppenheimer	Outperform
2024-07-26	Iniziato	Robert W. Baird	Outperform
2024-06-27	Iniziato	Cantor Fitzgerald	Overweight
2024-05-16	Iniziato	H.C. Wainwright	Buy
2024-02-15	Iniziato	Stifel	Buy
2023-12-26	Iniziato	Jefferies	Buy
2023-11-22	Iniziato	Wedbush	Outperform
2023-10-30	Iniziato	Guggenheim	Buy
2023-09-28	Iniziato	Raymond James	Outperform
2022-08-25	Downgrade	Goldman	Buy → Neutral
2022-01-06	Aggiornamento	Goldman	Neutral → Buy
2021-08-20	Ripresa	Goldman	Neutral
2021-08-03	Downgrade	JP Morgan	Overweight → Neutral
2021-07-22	Reiterato	B. Riley Securities	Buy
2021-06-29	Iniziato	Cantor Fitzgerald	Overweight
2021-06-15	Iniziato	BTIG Research	Buy
2021-05-18	Iniziato	B. Riley Securities	Buy
2021-01-07	Iniziato	Mizuho	Buy
2020-06-08	Aggiornamento	Goldman	Neutral → Buy
2019-03-25	Downgrade	Goldman	Buy → Neutral
2019-03-15	Iniziato	Raymond James	Outperform

Mostra tutto

Dianthus Therapeutics Inc Borsa (DNTH) Ultime notizie

07:28 AM

Dianthus Therapeutics completes enrollment for MaGic trial - Investing.com

07:28 AM

07:27 AM

Dianthus Therapeutics completes enrollment for MaGic trial By Investing.com - Investing.com India

07:27 AM

07:00 AM

Breakthrough gMG Treatment DNTH103 Hits Major Milestone: Phase 2 Results Coming This Fall - Stock Titan

07:00 AM

03:29 AM

Invesco Ltd. Purchases 790 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

03:29 AM

12:26 PM

TCG Crossover Management LLC Takes Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

12:26 PM

May 04, 2025

25,000 Shares in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Purchased by Allostery Investments LP - MarketBeat

May 04, 2025

Ally Bridge Group NY LLC Makes New Investment in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 04, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Stock Position Lowered by 5AM Venture Management LLC - MarketBeat

May 04, 2025

JPMorgan Chase & Co. Increases Stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

May 04, 2025

Dianthus Therapeutics (DNTH) to Release Quarterly Earnings on Thursday - MarketBeat

May 04, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap DownHere's What Happened - MarketBeat

May 04, 2025

May 03, 2025

Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) PT at $54.33 - MarketBeat

May 03, 2025

May 02, 2025

Adage Capital Partners GP L.L.C. Buys Shares of 180,000 Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 02, 2025

May 01, 2025

Legal & General Group Plc Buys 2,363 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

May 01, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 01, 2025

Apr 30, 2025

BlackRock, Inc. Reduces Stake in Dianthus Therapeutics Inc. - GuruFocus

Apr 30, 2025

Apr 29, 2025

Dianthus Therapeutics to Participate in Two Upcoming Investor Events - The Manila Times

Apr 29, 2025

Dianthus Therapeutics Reveals Growth Strategy at Two Elite Healthcare Investment Forums - Stock Titan

Apr 29, 2025

Apr 27, 2025

Dianthus Therapeutics (DNTH) Sees Rise in Short Interest Despite Stock Rebound | DNTH Stock News - GuruFocus

Apr 27, 2025

Apr 26, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 7.4%Time to Buy? - MarketBeat

Apr 26, 2025

Apr 25, 2025

Bain Capital Life Sciences Investors LLC Sells 323,716 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 25, 2025

Apr 24, 2025

Walleye Capital LLC Purchases 52,890 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 24, 2025

Apr 23, 2025

Dianthus Therapeutics: Complement Therapy Developer With Long Road Ahead - Seeking Alpha

Apr 23, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Bought by Geode Capital Management LLC - Defense World

Apr 23, 2025

Apr 21, 2025

Fmr LLC Purchases 36,133 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 21, 2025

Apr 19, 2025

Vanguard Group Inc. Sells 20,331 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 19, 2025

Apr 18, 2025

A stock that deserves closer examination: Dianthus Therapeutics Inc (DNTH) - uspostnews.com

Apr 18, 2025

Apr 14, 2025

Wellington Management Group LLP Boosts Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Apr 14, 2025

Apr 13, 2025

KLP Kapitalforvaltning AS Acquires New Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Apr 13, 2025

Apr 12, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by Corebridge Financial Inc. - Defense World

Apr 12, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Alliancebernstein L.P. - MarketBeat

Apr 12, 2025

Apr 11, 2025

ADAR1 Capital Management LLC Sells 101,055 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 11, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World

Apr 11, 2025

Apr 10, 2025

Brokerages Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Target Price at $54.33 - MarketBeat

Apr 10, 2025

Rhenman & Partners Asset Management AB Sells 36,000 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Apr 10, 2025

Apr 09, 2025